Alteration of cell cycle-related genes in hepatocarcinogenesis

Histology and Histopathology

Volumn 12, Issue 4, 1997, Pages 1019-1025

  Nishida, N ^a   Fukuda, Y ^a   Ishizaki, K ^b   Nakao, K ^a  

^a KYOTO UNIVERSITY   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

Cyclin D1; Hepatocellular carcinoma; p16; p53; RB

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE; PROTEIN P53;

CANCER GROWTH; CARCINOGENESIS; CELL CYCLE; CONTROLLED STUDY; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; REVIEW; TUMOR DIFFERENTIATION; TUMOR SUPPRESSOR GENE;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL CYCLE PROTEINS; HUMANS; LIVER NEOPLASMS;

MAMMALIA;

EID: 0030801640     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (9)

1. Aguilar F., Harris C.C., Sun T., Hollstein M. and Cerutti P. (1994). Geographic variation of p53 mutational profile in nonmalignant human liver. Science 264, 1317-1319.
2. Baldin V., Lukas J., Marcote M.J., Pagano M. and Draetta G. (1993). Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev. 7, 812-821.
3. Bressac B., Kew M., Wands J. and Ozturk M. (1991). Selective G to T mutation of p53 gene in hepatocellular carcinoma from southern Afrifca. Nature 350, 429-431.
4. Cairns P., Polascik T.J., Eby Y., Tokino K., Califano J., Merlo A., Mao L., Herath J., Jenkins R., Westra W., Rutter J.L., Buckler A., Gabrielson E., Tockman M., Cho K.R., Hedrick L., Bova G.S., Isaacs W., Koch W., Schwab D. and Sidransky D. (1995). Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nature Genet. 11, 210-212.
5. Caldas C., Hahn S.A., Costa L.T., Redston M.S., Schutte M., Seymour A.B., Weinstein C.L., Hruban R.H., Yeo C.J. and Kern S.E. (1994). Frequent somatic mutations and homozygous deletions of the p16(MTS1) gene in pancreatic adenocarcinoma. Nature Genet. 8, 27-32.
6. Chellappan S.P., Hiebert S., Mudryj M., Horowitz J.M. and Nevins J.R. (1991). The E2F transcripition factor is a cellular target for the RB protein. Cell 65, 1053-1061.
7. Yoshida S., Todoroki T., Ichikawa Y., Hanai S., Suzuki H., Hori M., Fukao K., Miwa M. and Uchida K. (1995). Mutations of p16INK4/CDKN2 and p15INK4B/MTS2 genes in biliary tract cancers. Cancer Res. 55, 2756-2760.
8. Zhang Y.J., Jiang W., Chen C.J., Lee C.S., Kahn S.M., Santella R.M. and Weinstein I.B. (1993). Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma. BBRC 196, 1010-1016.
9. Zhang X., Xu H.J., Murakami Y., Sachse R., Yashima K., Hirohashi S., Hu S.X., Benedict W.F. and Sekiya T. (1994). Deletions of chromosome 13q, mutations in retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma. Cancer Res. 54, 4177-4182.